Comparing the efficacy of prulifloxacin against cefixime as a preventive treatment before transrectal ultrasound guided prostate biopsy.

INTERVENTION: Patients eligible for prostate biopsy will receive either oral tablet prulifloxacin 600mg once daily for three days (Group 1) or oral tablet cefixime 400mg (Group 2) once daily for three days, as prevention treatment before biopsy. Monitoring will be based on high fever followed with lower urinary tract symptoms up to 3 days after the performance, The adherence to the treatment will be checked, as patinets are asked to recieve each drug some hours before biopsy, inside the urology department. CONDITION: Prostate cancer suspicious Urinary tract infection PRIMARY OUTCOME: High fever with lower urinary tract symptoms ; ; These will be chcked by self thermometry by the patient, as well as medical history is required. SECONDARY OUTCOME: Severe sepsis ; Evaluation will be performed with: ; ; Blood and urine examintaions and cultures. ; Blood gas, respiratory frequence, blood pressure. ; ; INCLUSION CRITERIA: Patients eligible for prostate biopsy